Medindia LOGIN REGISTER
Medindia

Anastrozole Interaction with other Drugs


Anastrozole is a non-steroidal inhibitor used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause.

Anastrozole Interaction with 65 drugs. Find out more in the list below:

Acetyldigitoxin


Acetyldigitoxin may decrease the cardiotoxic activities of Anastrozole.

Ancestim


The risk or severity of cytotoxicity can be increased when Ancestim is combined with Anastrozole.

Atorvastatin


The risk or severity of adverse effects can be increased when Anastrozole is combined with Atorvastatin.

Advertisement

Bevacizumab


Bevacizumab may increase the cardiotoxic activities of Anastrozole.

Bevacizumab-Awwb


Bevacizumab may increase the cardiotoxic activities of Anastrozole.

Bosutinib


The serum concentration of Bosutinib can be increased when it is combined with Anastrozole.

Advertisement

Bosutinib monohydrate


The serum concentration of Bosutinib can be increased when it is combined with Anastrozole.

Bromocriptine


The risk or severity of adverse effects can be increased when Bromocriptine is combined with Anastrozole.

Cabazitaxel


The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Anastrozole.

Advertisement

Cabergoline


The risk or severity of adverse effects can be increased when Cabergoline is combined with Anastrozole.

Cerivastatin


The serum concentration of Cerivastatin can be increased when it is combined with Anastrozole.

Chlorotrianisene


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Chlorotrianisene.

Cyclophosphamide


Cyclophosphamide may increase the cardiotoxic activities of Anastrozole.

Cyclophosphamide Anhydrous


Cyclophosphamide may increase the cardiotoxic activities of Anastrozole.

Deslanoside


Deslanoside may decrease the cardiotoxic activities of Anastrozole.

Dienestrol


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Dienestrol.

Diethylstilbestrol


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Diethylstilbestrol.

Digitoxin


Digitoxin may decrease the cardiotoxic activities of Anastrozole.

Digoxin


Digoxin may decrease the cardiotoxic activities of Anastrozole.

Dihydroergotamine


The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Anastrozole.

Docetaxel


The risk or severity of adverse effects can be increased when Docetaxel is combined with Anastrozole.

DOCETAXEL ANHYDROUS


The risk or severity of adverse effects can be increased when Docetaxel is combined with Anastrozole.

Equol, (-)-


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Equol.

Ergonovine


The risk or severity of adverse effects can be increased when Ergonovine is combined with Anastrozole.

Ergotamine


The risk or severity of adverse effects can be increased when Ergotamine is combined with Anastrozole.

Estradiol


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estradiol.

Estradiol acetate


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estradiol acetate.

Estradiol Cypionate


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estradiol cypionate.

Estradiol Valerate


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estradiol valerate.

Estriol


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estriol.

Estrogens, Conjugated (USP)


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Conjugated estrogens.

Estrogens, Esterified (USP)


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estrogens, esterified.

Estrone


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estrone.

Ethinyl Estradiol


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Ethinyl Estradiol.

Fluvastatin


The serum concentration of Fluvastatin can be increased when it is combined with Anastrozole.

Genistein


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Genistein.

Ibrutinib


The serum concentration of Ibrutinib can be increased when it is combined with Anastrozole.

Lisuride


The risk or severity of adverse effects can be increased when Lisuride is combined with Anastrozole.

Lovastatin


The serum concentration of Lovastatin can be increased when it is combined with Anastrozole.

Mestranol


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Mestranol.

Metergoline


The risk or severity of adverse effects can be increased when Metergoline is combined with Anastrozole.

Methadone


The serum concentration of Methadone can be increased when it is combined with Anastrozole.

Methylergonovine


The risk or severity of adverse effects can be increased when Methylergometrine is combined with Anastrozole.

Methysergide


The risk or severity of adverse effects can be increased when Methysergide is combined with Anastrozole.

Nicergoline


The risk or severity of adverse effects can be increased when Nicergoline is combined with Anastrozole.

Ouabain


Ouabain may decrease the cardiotoxic activities of Anastrozole.

Ovine Digoxin Immune Fab


Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Anastrozole.

Paclitaxel


The risk or severity of adverse effects can be increased when Paclitaxel is combined with Anastrozole.

Pergolide


The risk or severity of adverse effects can be increased when Pergolide is combined with Anastrozole.

Pitavastatin


The serum concentration of Pitavastatin can be increased when it is combined with Anastrozole.

Polyestradiol Phosphate


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Polyestradiol phosphate.

Pravastatin


The serum concentration of Pravastatin can be increased when it is combined with Anastrozole.

Promestriene


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Promestriene.

Proscillaridin


Proscillaridin may decrease the cardiotoxic activities of Anastrozole.

Quinestrol


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Quinestrol.

Rilpivirine


The serum concentration of Rilpivirine can be increased when it is combined with Anastrozole.

Rosuvastatin


The serum concentration of Rosuvastatin can be increased when it is combined with Anastrozole.

Simvastatin


The serum concentration of Simvastatin can be increased when it is combined with Anastrozole.

synthetic conjugated estrogens, A


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Synthetic Conjugated Estrogens, A.

synthetic conjugated estrogens, B


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Synthetic Conjugated Estrogens, B.

Tamoxifen


The serum concentration of Anastrozole can be decreased when it is combined with Tamoxifen.

Tibolone


The therapeutic efficacy of Anastrozole can be decreased when used in combination with Tibolone.

Tizanidine


The serum concentration of Tizanidine can be increased when it is combined with Anastrozole.

Tolvaptan


The serum concentration of Tolvaptan can be increased when it is combined with Anastrozole.

Trastuzumab


Trastuzumab may increase the cardiotoxic activities of Anastrozole.

Advertisement
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mastering Diabetes: A Comprehensive Guide to Education and Self-Care – An Ebook
Stay Connected
Available on the Android Market Available on the App Store

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional